ICAM1 and neoplasm: Upregulated ICAM‐1 expression required the activation of PLCβ via tyrosine kinase to induce PKCα and c‐Src, allowing the transcriptional factors to bind on the AP‐1 promoter binding sites for tumour cell motility.58, 59